Skip to main content
Top
Published in: Clinical Oral Investigations 8/2020

Open Access 01-08-2020 | Tooth Extraction | Original Article

Increased risk for tooth extraction in primary hyperparathyroidism and hypercalcemia: a population study

Authors: A. Koman, P. Näsman, A. Discacciati, A. Ekbom, I-L. Nilsson, G. Sandborgh-Englund

Published in: Clinical Oral Investigations | Issue 8/2020

Login to get access

Abstract

The aim of this study was to analyze dental comorbidities in untreated primary hyperparathyroidism (pHPT). Patients with pHPT subjected to parathyroidectomy (PTX) at Karolinska University Hospital, Stockholm, during 2011–2016 (n = 982) were selected from the Scandinavian Quality Register of Thyroid, Parathyroid and Adrenal surgery and compared to a general population cohort (n = 2944), matched for age and gender. Dental data was obtained from the Swedish Dental Health Registry for the 3 years prior to PTX. The incidence rate ratios (IRRs) of tooth loss by extraction, periodontal interventions, and dental visit rate were analyzed by Poisson regression models. In order to analyze the impact of disease severity, the PHPT cohort was sub-grouped based on preoperative serum levels of ionized calcium (S-Ca2+). The total number of tooth extractions, periodontal interventions, and number of visits were similar in the cohorts. PHPT patients belonging to the quartile with the highest S-Ca2+ (≥ 1.51 mmol/L) had increased risk for tooth extraction (IRR 1.85; 95% CI 1.39–2.46). Female gender independently amplified the risk (IRR 1.341, P < 0.027). This study indicates an association between pHPT and oral disorders reflected by increased tooth loss by extraction related to high S-Ca2. Increased awareness of dental comorbidity in primary hyperparathyroidism may benefit a large group of patients with a common disease through earlier detection and prevention.
Appendix
Available only for authorised users
Literature
2.
go back to reference Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, Thakker R, D'Amour P, Paul T, Van Uum S, Shrayyef MZ, Goltzman D, Kaiser S, Cusano NE, Bouillon R, Mosekilde L, Kung AW, Rao SD, Bhadada SK, Clarke BL, Liu J, Duh Q, Lewiecki EM, Bandeira F, Eastell R, Marcocci C, Silverberg SJ, Udelsman R, Davison KS, Potts JT Jr, Brandi ML, Bilezikian JP (2017) Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int 28:1–19. https://doi.org/10.1007/s00198-016-3716-2 CrossRefPubMed Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, Thakker R, D'Amour P, Paul T, Van Uum S, Shrayyef MZ, Goltzman D, Kaiser S, Cusano NE, Bouillon R, Mosekilde L, Kung AW, Rao SD, Bhadada SK, Clarke BL, Liu J, Duh Q, Lewiecki EM, Bandeira F, Eastell R, Marcocci C, Silverberg SJ, Udelsman R, Davison KS, Potts JT Jr, Brandi ML, Bilezikian JP (2017) Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int 28:1–19. https://​doi.​org/​10.​1007/​s00198-016-3716-2 CrossRefPubMed
4.
go back to reference Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Solorzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE (2016) The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg 151:959–968. https://doi.org/10.1001/jamasurg.2016.2310 CrossRefPubMed Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Solorzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE (2016) The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg 151:959–968. https://​doi.​org/​10.​1001/​jamasurg.​2016.​2310 CrossRefPubMed
5.
go back to reference Silverman S Jr, Ware WH, Gillooly C Jr (1968) Dental aspects of hyperparathyroidism. Oral Surg Oral Med Oral Pathol 26:184–189CrossRef Silverman S Jr, Ware WH, Gillooly C Jr (1968) Dental aspects of hyperparathyroidism. Oral Surg Oral Med Oral Pathol 26:184–189CrossRef
8.
go back to reference Meurman JH, Sanz M, Janket SJ (2004) Oral health, atherosclerosis, and cardiovascular disease. Crit Rev Oral Biol Med 15:403–413CrossRef Meurman JH, Sanz M, Janket SJ (2004) Oral health, atherosclerosis, and cardiovascular disease. Crit Rev Oral Biol Med 15:403–413CrossRef
26.
go back to reference D’Aiuto F, Gkranias N, Bhowruth D, Khan T, Orlandi M, Suvan J, Masi S, Tsakos G, Hurel S, Hingorani AD, Donos N, Deanfield JE and Group T (2018) Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial. Lancet Diabetes Endocrinol 6:954–965. doi: https://doi.org/10.1016/S2213-8587(18)30038-X CrossRefPubMed D’Aiuto F, Gkranias N, Bhowruth D, Khan T, Orlandi M, Suvan J, Masi S, Tsakos G, Hurel S, Hingorani AD, Donos N, Deanfield JE and Group T (2018) Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial. Lancet Diabetes Endocrinol 6:954–965. doi: https://​doi.​org/​10.​1016/​S2213-8587(18)30038-X CrossRefPubMed
Metadata
Title
Increased risk for tooth extraction in primary hyperparathyroidism and hypercalcemia: a population study
Authors
A. Koman
P. Näsman
A. Discacciati
A. Ekbom
I-L. Nilsson
G. Sandborgh-Englund
Publication date
01-08-2020
Publisher
Springer Berlin Heidelberg
Published in
Clinical Oral Investigations / Issue 8/2020
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-019-03137-y

Other articles of this Issue 8/2020

Clinical Oral Investigations 8/2020 Go to the issue